Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Spruce Biosciences Inc (SPRB)

Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spruce Biosciences Inc 611 GATEWAY BOULEVARD SUITE 740 SOUTH SAN FRANCISCO CA 94080 USA

www.sprucebiosciences.com Employees: 21 P: 415-655-4168

Sector:

Medical

Description:

Spruce Biosciences Inc. is a biopharmaceutical company. It focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy which are in clinical stage. Spruce Biosciences Inc. is based in Daly City, California.

Key Statistics

Overview:

Market Capitalization, $K 53,220
Enterprise Value, $K 16,210
Shares Outstanding, K 1,070
Float, K 997
% Float 93.10%
Short Interest, K 72
Short Float 6.71%
Days to Cover 2.99
Short Volume Ratio 0.70
% of Insider Shareholders 6.90%
% of Institutional Shareholders 91.71%

Financials:

Annual Sales, $ 4,910 K
Annual Net Income, $ -53,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,210 K
EBIT, $ -49,480 K
EBITDA, $ -49,430 K

Growth:

1-Year Return 55.95%
3-Year Return -69.87%
5-Year Return -96.83%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -14.58 on 11/10/25
Next Earnings Date 04/21/26
Earnings Per Share ttm -85.00
EPS Growth vs. Prev Qtr -316.57%
EPS Growth vs. Prev Year 7.66%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-75 on 08/07/25

SPRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -305.39%
Return-on-Assets % -168.01%
Profit Margin % -1,080.24%
Debt/Equity 0.10
Price/Sales 41.41
Price/Cash Flow N/A
Price/Book 4.91
Book Value/Share 10.78
Interest Coverage -170.10
60-Month Beta 3.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar